-
Loading metrics
The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance
- Michael Bobardt,
- Christina M. Ramirez,
- Marc M. Baum,
- Daren Ure,
- Robert Foster,
- Philippe A. Gallay
x
- Published: May 20, 2021
- https://doi.org/10.1371/journal.pone.0251934